Skip to content
The People's CodeSearch
Menu

Changes to the Code

H.R. 1492 · To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. ·

In committee · step 2 of 5

Sections are cited like “7 U.S.C. § 2012”: 7 of the , 2012.

42 U.S.C. § 1320f–1 Selection of negotiation-eligible drugs as selected drugs

+1 −1Shown
More for 42 U.S.C. § 1320f–1
Read § 1320f–1Only this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Section 1192(e)(1)(A)(ii) of the Social Security Act (42 U.S.C. 1320f–1(e)(1)(A)(ii)) is amended by striking 7 years and inserting 11 years.

§ 1320f–1(e)(1)In general(A)–(B)

Start of § 1320f–1 to (e)(1)(A) unchanged ·

(i) that is approved under section 355(c) of title 21 and is marketed pursuant to such approval;

(ii) for which, as of the selected drug publication date with respect to such initial price applicability year, at least [struck: 7][inserted: 11] years will have elapsed since the date of such approval; and

(iii) that is not the listed drug for any drug that is approved and marketed under section 355(j) of such title.

(B) Biological products A biological product—

Rest of § 1320f–1 unchanged ·

Step through the changes